chr1-17000275-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_022089.4(ATP13A2):​c.878T>C​(p.Met293Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000126 in 1,434,192 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000029 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000011 ( 0 hom. )

Consequence

ATP13A2
NM_022089.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.05

Publications

0 publications found
Variant links:
Genes affected
ATP13A2 (HGNC:30213): (ATPase cation transporting 13A2) This gene encodes a member of the P5 subfamily of ATPases which transports inorganic cations as well as other substrates. Mutations in this gene are associated with Kufor-Rakeb syndrome (KRS), also referred to as Parkinson disease 9. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2008]
ATP13A2 Gene-Disease associations (from GenCC):
  • Kufor-Rakeb syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, G2P, ClinGen
  • autosomal recessive spastic paraplegia type 78
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • parkinsonism due to ATP13A2 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0683935).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP13A2NM_022089.4 linkc.878T>C p.Met293Thr missense_variant Exon 10 of 29 ENST00000326735.13 NP_071372.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP13A2ENST00000326735.13 linkc.878T>C p.Met293Thr missense_variant Exon 10 of 29 1 NM_022089.4 ENSP00000327214.8 Q9NQ11-1

Frequencies

GnomAD3 genomes
AF:
0.0000289
AC:
4
AN:
138258
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000614
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
197236
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000108
AC:
14
AN:
1295934
Hom.:
0
Cov.:
37
AF XY:
0.00000781
AC XY:
5
AN XY:
640430
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28932
American (AMR)
AF:
0.00
AC:
0
AN:
35336
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
20494
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25494
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80636
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5006
European-Non Finnish (NFE)
AF:
0.0000139
AC:
14
AN:
1009090
Other (OTH)
AF:
0.00
AC:
0
AN:
50320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000289
AC:
4
AN:
138258
Hom.:
0
Cov.:
31
AF XY:
0.0000302
AC XY:
2
AN XY:
66270
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
37586
American (AMR)
AF:
0.00
AC:
0
AN:
12808
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3352
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3984
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8162
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
276
European-Non Finnish (NFE)
AF:
0.0000614
AC:
4
AN:
65116
Other (OTH)
AF:
0.00
AC:
0
AN:
1932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000726
Hom.:
0
Bravo
AF:
0.0000151
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Kufor-Rakeb syndrome;C5567893:Autosomal recessive spastic paraplegia type 78 Uncertain:1
Oct 25, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ATP13A2 protein function. This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 293 of the ATP13A2 protein (p.Met293Thr). This variant is present in population databases (rs772414750, gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ATP13A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 567424). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Inborn genetic diseases Uncertain:1
Mar 22, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.878T>C (p.M293T) alteration is located in exon 10 (coding exon 10) of the ATP13A2 gene. This alteration results from a T to C substitution at nucleotide position 878, causing the methionine (M) at amino acid position 293 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Uncertain
0.019
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
14
DANN
Benign
0.81
DEOGEN2
Benign
0.23
T;.;.;.;T;T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.60
T;T;T;T;T;T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.068
T;T;T;T;T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
-0.97
N;.;.;.;.;.
PhyloP100
2.1
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.43
N;N;N;.;N;N
REVEL
Benign
0.28
Sift
Benign
0.20
T;T;T;.;T;T
Sift4G
Benign
0.34
T;T;T;T;T;.
Polyphen
0.0
B;.;.;.;.;.
Vest4
0.18
MutPred
0.55
Gain of phosphorylation at M293 (P = 0.0241);.;.;.;.;.;
MVP
0.71
MPC
0.37
ClinPred
0.044
T
GERP RS
3.7
PromoterAI
-0.0052
Neutral
Varity_R
0.037
gMVP
0.42
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772414750; hg19: chr1-17326770; API